Novartis Withdraws Application for Prexige
257211
Swiss pharmaceutical giant Novartis AG said Tuesday it is temporarily withdrawing an application for European Union approval of its painkiller Prexige, but added that it will present new data this week to prove the safety and effectiveness of the drug.
418461
Hard time after swilling extra vits A US man is suing Novartis pharmaceutical company after its Boost Plus health drink allegedly provoked a nasty case of severe priapism.â¦
114882
Under pressure for more data on the long-term safety effects of its Intrinsa testosterone patch, Procter &amp; Gamble Co. has withdrawn its application to the US Food and Drug Administration to market the patch.
86750
A prescription painkiller used by more than 250,000 Australians to treat arthritis has been withdrawn from sale after a clinical trial found it doubled the risk of heart attack and stroke.
585919
The company withdrew its application to gain federal approval for a weight loss drug after a meeting at which government advisers rejected the treatment on safety grounds.
458682
Ex arbitro malato di Sla accetta di prendere farmaci
259284
Its 'been delivering' Accenture, the IT and consultancy firm has avoided huge penalty fees for withdrawing from the UK National Programme for IT (NPfIT).â¦
40636
Ponders withdrawing support for non-stickered product
374438
Vioxx, the blockbuster arthritis drug heavily promoted on TV and taken by some 2 million people worldwide, was pulled from the market by its maker yesterday after a study found it doubled the risk of heart attacks and strokes.
533556
Shares of SuperGen Inc. SUPG.O  dropped 17 percent before the bell on Monday after the company  said it withdrew an application to market its pancreatic cancer  treatment in the United States due to insufficient data.
250837
U.S. regulators have not approved Novartis AG's Prexige painkiller, the Swiss drugmaker said on Thursday, a move that had been expected after Australia withdrew the drug on concerns over liver side-effects.
48213
Sanofi-Aventis said on Friday it was withdrawing its application to sell obesity drug rimonabant -- its biggest new drug hope -- in the United States.
422908
- Bayer HealthCare, a U.S.-based unit of Bayer AG , stopped a late-stage trial of Nexavar in patients with non-small cell lung cancer, after an independent data monitoring committee concluded that the study would not meet the main goal of improved overall survival.
44221
Novartis AG  cut its full-year results outlook as generic competition pressured sales of a key blood-pressure drug, and said U.S. regulators had delayed the approval process for an important cancer treatment.
287612
Pulling an application for Iressa from the EU makes the drug a has-been.
18611
SuperGen Inc. on Monday said it has  withdrawn an application to market its pancreatic cancer  treatment in the United States due to insufficient data,  sending its shares down 17 percent.
86858
GenVec Inc. has suspended human testing of its leading drug, a potential cancer therapy, after a patient died during a study. The Gaithersburg biotechnology company&#39;s stock plunged